Page 21 - Vaccine

CDC panel recommends Pfizer, Moderna Covid vaccines over J&J shot

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations while the Pfizer and Moderna vaccines don't come with that risk and also appear to be more effective, advisers to the Centers for Disease Control and Prevention said. It's an unusual move and the CDC's director, Dr. Rochelle Walensky, must decide whether to accept the panel's advice. Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J's vaccine initially was welcomed as a single-dose option that could be especially important for hard-to-reach groups like homeless people who might not get the needed second dose of the Pfizer or Moderna options. But the CDC's ..

Booster shots for 40+ and frontline workers to cost govt another Rs 10k cr

If booster shots are given on priority, the pace of vaccination may slow further. In the worst case scenario, the country will take till mid-March to vaccinate its entire adult population partially.

Our vaccines may become ineffective in emerging situations, says V K Paul

"We need 7.2 billion doses together, and with the current rate of production, it is well within our grasp... it is possible for us to deliver the vaccine," Paul said

India to produce 5 billion Covid vaccine doses next year: Piyush Goyal

Goyal said India was ready to export as many doses as partner nations require

Vaccine booster shots: Experts studying benefits before India forges ahead

Some experts also argue that companies sitting on big vaccine stocks are using boosters as a marketing strategy to sell more vaccines

CMC Vellore calls for volunteers for Covaxin vaccine booster dose trials

The findings for recipients of Covishield will be released along with those with Covaxin trial data once the study for both vaccines is over

Over 132 crore Covid vaccine doses administered in India so far: Govt

The countrywide vaccination drive was rolled out on January 16

Will vaccine crunch hurt India's ongoing fight against Covid-19?

Serum Institute is going to cut down production of Covishield as there's no order from the govt. But some states don't have enough vaccine in store. Find out if India is well-stocked to fight Covid-19

Vladimir Putin hopes WHO soon approves Russia's Sputnik V vaccine

Russia was the first country in the world to authorise a coronavirus vaccine, launching Sputnik V in August 2020, and has plentiful supplies

Vaccine hoarding by some countries leading to new Covid-19 variants?

Just as we thought that we were out of the woods, the threat of a new Covid-19 variant, Omicron, has started looming large. Let's take a look at the factors that have contributed to the crisis

Russia starts developing new Covid-19 vaccine against Omicron variant

If modification is needed, the new Sputnik Omicron version can be ready for mass production in 45 days

Centre to review flight resumption as new Covid-19 variant sparks alert

No cases of the variant, which was first reported to the World Health Organisation (WHO) from South Africa on November 24, have been recorded in India

AstraZeneca examining impact of new Covid-19 variant on vaccine

The company has also developed an antibody cocktail which can be used both to prevent and to treat Covid-19

Over 120.96 cr Covid vaccine doses administered in India so far: Govt

The country launched vaccination for all people aged more than 45 years from April 1

India delivered 70.70 mn Covid-19 vaccine doses to 95 countries: Govt

The remaining 58 million were supplied by the Serum Institute of India under its commercial and COVAX obligations

Sputnik Light Covid-19 vaccine to be launched in India by December

Russian Direct Investment Fund has Serum Institute as its production partner in India

Over 120 cr Covid vaccine doses administered in India so far: Govt

The next phase of Covid-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified comorbid conditions

VAV Life Sciences unit to reach 40% of global mRNA lipid capacity next yr

Firm expanding mRNA lipids capacity 10-fold, overall plant capacity by 6 times by June

Over 118 crore Covid vaccine doses administered in India so far: Govt

The next phase of Covid-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions

Over 117 crore Covid vaccine doses administered in India: Govt

The country launched vaccination for all people aged above 45 years from April 1